• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有取代羟基喹啉的抗癌钌(II)配合物的构效关系。

Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines.

机构信息

Department of Chemistry, University of Kentucky, 505 Rose Street, Lexington, KY 40506, United States.

Department of Chemistry, University of Kentucky, 505 Rose Street, Lexington, KY 40506, United States.

出版信息

Eur J Med Chem. 2018 Aug 5;156:790-799. doi: 10.1016/j.ejmech.2018.04.044. Epub 2018 Apr 30.

DOI:10.1016/j.ejmech.2018.04.044
PMID:30055464
Abstract

8-Hydroxyquinolines (HQ), including clioquinol, possess cytotoxic properties and are widely used as ligands for metal-based anticancer drug research. The number and identity of substituents on the HQ can have a profound effect on activity for a variety of inorganic compounds. Ruthenium complexes of HQ exhibit radically improved potencies, and operate by a new, currently unknown, mechanism of action. To define structure-activity relationships (SAR), a family of 22 Ru(II) coordination complexes containing mono-, di- and tri-substituted hydroxyquinoline ligands were synthesized and their biological activity evaluated. The complexes exhibited promising cytotoxic activity against a cancer cell line, and the SAR data revealed the 2- and 7-positions as key sites for the incorporation of halogens to improve potency. The Ru(II) complexes potently inhibited translation, as demonstrated by an in-cell translation assay. The effects were seen at 2-15-fold higher concentrations than those required to observe cytotoxicity, suggesting that prevention of protein synthesis may be a primary, but not the exclusive mechanism for the observed cytotoxic activity.

摘要

8-羟基喹啉(HQ),包括氯碘羟喹,具有细胞毒性,广泛用作基于金属的抗癌药物研究的配体。HQ 上取代基的数量和种类对各种无机化合物的活性有深远的影响。HQ 的钌配合物表现出明显改善的效力,并且通过一种新的、目前未知的作用机制起作用。为了定义构效关系(SAR),合成了一系列包含单、二和三取代羟基喹啉配体的 22 个 Ru(II)配位配合物,并评估了它们的生物活性。这些配合物对癌细胞系表现出有希望的细胞毒性活性,SAR 数据表明 2-和 7-位是引入卤素以提高效力的关键部位。如细胞内翻译测定所示,Ru(II)配合物强烈抑制翻译。在比观察到细胞毒性所需的浓度高 2-15 倍的浓度下观察到这些效果,这表明蛋白质合成的抑制可能是观察到的细胞毒性活性的主要但不是唯一的机制。

相似文献

1
Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines.具有取代羟基喹啉的抗癌钌(II)配合物的构效关系。
Eur J Med Chem. 2018 Aug 5;156:790-799. doi: 10.1016/j.ejmech.2018.04.044. Epub 2018 Apr 30.
2
Coordination of hydroxyquinolines to a ruthenium bis-dimethyl-phenanthroline scaffold radically improves potency for potential as antineoplastic agents.羟基喹啉与钌双二甲基菲咯啉支架的配位极大地提高了作为抗肿瘤药物的潜力。
J Med Chem. 2014 Nov 13;57(21):8936-46. doi: 10.1021/jm501043s. Epub 2014 Nov 3.
3
Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.含P^P螯合配体的半夹心铱(III)和钌(II)配合物:一类具有异常氧化还原特性的新型强效抗癌剂。
Inorg Chem. 2018 Feb 19;57(4):1705-1716. doi: 10.1021/acs.inorgchem.7b01959. Epub 2018 Feb 5.
4
Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.与碳、氮和氧配体配位的(芳烃)钌(II)配合物的抗癌活性及作用方式
Mini Rev Med Chem. 2016;16(10):804-14. doi: 10.2174/138955751610160503004623.
5
Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.调控钌(II)-芳烃配合物的抗癌活性
J Med Chem. 2015 Apr 23;58(8):3356-65. doi: 10.1021/jm501655t. Epub 2015 Apr 7.
6
Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.引入4-苯基-1,2,3-三唑部分作为一种通用骨架,用于开发具有细胞毒性的钌(II)和锇(II)芳烃环金属配合物。
Inorg Chem. 2017 Jan 3;56(1):528-541. doi: 10.1021/acs.inorgchem.6b02430. Epub 2016 Dec 20.
7
Arene Ruthenium(II) Complexes with Phosphorous Ligands as Possible Anticancer Agents.作为潜在抗癌剂的含磷配体芳基钌(II)配合物
Chimia (Aarau). 2017 Sep 27;71(9):573-579. doi: 10.2533/chimia.2017.573.
8
Comparative solution equilibrium studies of antitumor ruthenium(η-p-cymene) and rhodium(η-CMe) complexes of 8-hydroxyquinolines.抗肿瘤钌(η-p-环戊二烯)和铑(η-CMe)配合物的 8-羟基喹啉的比较溶液平衡研究。
Dalton Trans. 2017 Mar 27;46(13):4382-4396. doi: 10.1039/c7dt00439g.
9
Anticancer Ru(η-p-cymene) complexes of 2-pyridinecarbothioamides: A structure-activity relationship study.抗癌钌(η-p-枯烯)配合物的 2-吡啶碳硫酰胺:构效关系研究。
J Inorg Biochem. 2017 Dec;177:395-401. doi: 10.1016/j.jinorgbio.2017.08.034. Epub 2017 Sep 4.
10
Synthesis and biological characterization of organoruthenium complexes with 8-hydroxyquinolines.含 8-羟基喹啉的有机钌配合物的合成及生物学特性研究。
J Inorg Biochem. 2018 Sep;186:187-196. doi: 10.1016/j.jinorgbio.2018.05.009. Epub 2018 May 19.

引用本文的文献

1
A glimpse into the developments, potential leads and future perspectives of anticancer cobalt complexes.抗癌钴配合物的发展、潜在线索及未来展望一瞥。
RSC Med Chem. 2025 Jun 24. doi: 10.1039/d5md00323g.
2
New triazole-based coordination complexes as antitumor agents against triple negative breast cancer MDA-MB-468 cell line.新型基于三唑的配位络合物作为抗三阴性乳腺癌MDA-MB-468细胞系的抗肿瘤剂。
RSC Adv. 2023 Dec 12;13(51):36158-36167. doi: 10.1039/d3ra07714d. eCollection 2023 Dec 8.
3
Biological Investigations of Ru(II) Complexes With Diverse β-diketone Ligands.
含多种β-二酮配体的钌(II)配合物的生物学研究
Eur J Inorg Chem. 2021 Sep 21;2021(35):3611-3621. doi: 10.1002/ejic.202100468. Epub 2021 Jul 21.
4
Avobenzone incorporation in a diverse range of Ru(II) scaffolds produces potent potential antineoplastic agents.阿伏苯宗在多种钌(II)支架中的掺入产生了有效的潜在抗肿瘤剂。
Dalton Trans. 2020 Sep 15;49(35):12161-12167. doi: 10.1039/d0dt02016h.
5
Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy.基于吡啶基吡唑(啉)的钌(II)配合物的光化学和光生物学性质及其亚微摩尔细胞毒性用于光疗
ACS Omega. 2020 Jul 23;5(30):18894-18906. doi: 10.1021/acsomega.0c02079. eCollection 2020 Aug 4.
6
Eighteen 5,7-Dihalo-8-quinolinol and 2,2'-Bipyridine Co(II) Complexes as a New Class of Promising Anticancer Agents.十八种5,7-二卤代-8-喹啉醇与2,2'-联吡啶钴(II)配合物作为一类新型有前景的抗癌剂
ACS Med Chem Lett. 2019 Oct 30;10(12):1603-1608. doi: 10.1021/acsmedchemlett.9b00356. eCollection 2019 Dec 12.